Israeli researchers develop promising new HIV treatment

Afp
Sunday 05 September 2010 19:00 EDT
Comments
(Sebastian Kaulitzki)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Israeli researchers have developed a new treatment for HIV that kills human cells infected with the virus and could lead to a breakthrough in treating AIDS, the Haaretz newspaper said on Friday.

Whereas current treatments focus on inhibiting the replication of the HIV virus, the new treatment destroys infected cells without damaging healthy ones, the newspaper said.

The process makes use of peptides, or short protein segments, which vastly increase the replications of the virus once it enters a cell, causing the cell's self-destruction, Haaretz said, citing one of the researchers.

"The usual medications kill the virus that has entered the body during infection and the (peptide) treatment allows cells infected with the genetic load of the virus to be killed," Abraham Loyter, who carried out the study, was quoted as saying.

The study was published in the peer-reviewed British journal "AIDS Research and Therapy" in August and was co-authored by Loyter, Aviad Levin, Zvi Hayouka, and Assaf Friedler.

The researchers could not be reached on Friday, a day off in Israel.

They have registered an Israeli patent but the treatment must still be tested on animals and humans, Haaretz said.

Around 33.4 million people suffer from the human immunodeficiency virus (HIV) which causes AIDS. The vast majority, more than 30 million, live in low and middle-income countries, according to the World Health Organisation.

ms/jk/al

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in